Prevention of age-induced N(epsilon)-(carboxymethyl)lysine accumulation in the microvasculature

Wessel W. Fuijkschot, Hjalmar J. de Graaff, Ekatarina Berishvili, Zurab Kakabadze, Koba Kupreishvili, Elisa Meinster, Maaike Houtman, Amber van Broekhoven, Casper G. Schalkwijk, Alexander B. A. Vonk, Paul A. J. Krijnen, Yvo M. Smulders, Hans W. N. Niessen

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)334-341
JournalEuropean Journal of Clinical Investigation
Volume46
Issue number4
DOIs
Publication statusPublished - Apr 2016

Keywords

  • Advanced glycation end products
  • age-related pathology
  • docosahexaenoic acid
  • microvasculature
  • N(epsilon)-(carboxymethyl)lysine (CML)

Cite this

Fuijkschot, W. W., de Graaff, H. J., Berishvili, E., Kakabadze, Z., Kupreishvili, K., Meinster, E., Houtman, M., van Broekhoven, A., Schalkwijk, C. G., Vonk, A. B. A., Krijnen, P. A. J., Smulders, Y. M., & Niessen, H. W. N. (2016). Prevention of age-induced N(epsilon)-(carboxymethyl)lysine accumulation in the microvasculature. European Journal of Clinical Investigation, 46(4), 334-341. https://doi.org/10.1111/eci.12599